Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Early hemorrhage control isn’t just about stopping bleeding – it’s about improving patient outcomes.
Every minute of uncontrolled bleeding increases the risk of hemorrhagic shock, coagulopathy, organ dysfunction, greater transfusion requirements, and mortality. That’s why time to hemostasis is one of the most important factors in trauma and surgical care.
Our latest white paper explores how WoundClot supports early hemorrhage management across the continuum of care—from the point of injury and emergency departments to operating rooms, postoperative care, vascular access, and austere environments.
Key highlights include:
- Broad-spectrum use across appropriate accessible bleeding environments
- FDA-cleared in the U.S. as a hemostatic wound dressing and used internationally as a Class III implantable and bioresorbable surgical hemostat in over 50 countries
- More than a decade of clinical and commercial use with no reported product-related adverse events in company post-market surveillance
- A unique expanding gel-matrix technology that conforms to complex wounds, adheres to tissue, and helps create an effective localized hemostatic environment
- Evidence supporting the importance of earlier hemostasis in reducing mortality and major complications
The goal isn’t simply to stop bleeding – it’s to control hemorrhage early enough to prevent avoidable deterioration.
Every minute matters. Every drop counts.”

Stay updated with Hemostasis Today.
-
Aug 16, 2026, 12:16Jeff Schaffnit: The Power of Community in Rare Blood Disorders
-
Aug 16, 2026, 12:03Fawaz AlOtaibi: Can AI Replace Contrast CTA for Vascular Screening?
-
Aug 16, 2026, 10:31Erhabor Osaro: Critical Issues to Consider During the Clinical Blood Transfusion Process
-
Aug 16, 2026, 10:14Juan Manuel Cisneros Carrasco: The Architects Behind the Blood Donation System
-
Aug 16, 2026, 10:06Honoring the Life and Legacy of Dr. Reed Pyeritz – GADA Canada
-
Aug 16, 2026, 09:51Javier Amador-Castañeda: When a 32 Percent Reduction Tells Only Part of the Story
-
Aug 16, 2026, 09:33Anıl Güneş: The Unseen Threat – How Global Climate Change Impacts Cardiovascular Health
-
Aug 16, 2026, 09:09Robert John Nesbitt: Can We Prevent Stroke Without Increasing Bleeding Risk
-
Aug 16, 2026, 06:19Dennis Wolf: Is ZEUS the End of Anti-Inflammatory Therapy in Atherosclerosis?